BIT
Click for more information
0.00% 3.3¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-58

  1. a2zz
    640 Posts.
    lightbulb Created with Sketch. 96
    clock Created with Sketch.
    19/06/24
    11:59
    Post #: 74387398
    Final resutls are going to be part by part drama that has been being staged and performed by actors and actress MM sponsored by the generous SHs and tax payers. Regulators are happy witht the performance of the actress, MM. A story created by Peter Gaze was commenetd by the contemporaries - https://www.copyright link/politics/dangerous-liaisons-20020222-jk8fm
    BIT Price at posting: 5.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LKE Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach
right-arrow Created with Sketch.
NEWS Warren Tredrea’s weekly sports business wrap: the latest on business in sport
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
I88 Major fault system and magnetic anomalies discovered at Talus Uranium Prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $29.77M
Open High Low Value Volume
3.3¢ 3.5¢ 3.2¢ $8.822K 265.5K

Buyers (Bids)

No. Vol. Price($)
1 45155 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 65500 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.